AzTrials
AzTrials

Abdominal TraumaGOAL-TraumaNCT06180668

Global Outcomes After Laparotomy for Trauma

An observational study of Abdominal Trauma, run by University of Cambridge.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to assessing the global variation in patient characteristics, management, and outcomes in those undergoing trauma laparotomy. The main questions it aims to answer are: What are the post-operative mortality rates for patients undergoing a trauma laparotomy globally What are the… Read more about this study

Who is it for?
Any age
Conditions the study is for
Abdominal Trauma
What is being tested?
Trauma Laparotomy
Type of treatment
Surgery or procedure
How many people
552 participants
Where
No sites listed yet
Study dates
Apr 2024to Feb 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients undergoing a trauma laparotomy for either a blunt or penetrating injury within 5 days of presenting to the treating centre.

Who may be able to join

  • Any patients of any ages who presents to hospital with a blunt or penetrating injury and undergo a trauma laparotomy within 5 days of presentation to the treating centre

Who cannot join

  • Patients undergoing a laparotomy ≥ 5 days (i.e. 120 hours) since presentation to the treating centre
  • Any relook laparotomy, including transfers from another centre for further and / or definitive surgery
  • Any laparoscopic (including laparoscopic converted to open), robotic, or image-guided procedures
  • Patients who have been recently discharged from any hospital (including for non-trauma related admissions) and have represented within 30 days of discharge

Trial locations and contacts

No sites are listed yet.

Michael F Bath, MBChB contact

+44 (0)1223748577

mb2583@cam.ac.uk

Tom Bashford, PhD contact

tb508@cam.ac.uk

About this study

Official title: Global Outcomes After Laparotomy for Trauma: The GOAL-Trauma Study

The goal of this observational study is to assessing the global variation in patient characteristics, management, and outcomes in those undergoing trauma laparotomy.

The main questions it aims to answer are:

Read more
  • What are the post-operative mortality rates for patients undergoing a trauma laparotomy globally
  • What are the epidemiological characteristics (demographics, injury characteristics, baseline clinical characteristics, and surgical case mix) for patients undergoing a trauma laparotomy
  • What are the pre-operative, peri-operative, and post-operative processes of care for patients undergoing a trauma laparotomy

This is a purely observational study on patients undergoing trauma laparotomy, with no direct change to clinical care.

Read the detailed description

We will conduct a prospective multi-centre observational cohort study of patients undergoing a trauma laparotomy. We will recruit centres through pre-existing research networks, utilising a snowballing technique to expand registration of centres. We will enrol eligible patients undergoing emergency trauma laparotomy over a consecutive 30 day period at individual centres during the study dates, with patients followed until discharge, death, or 30 days post-operatively, whichever comes first. All data will be submitted to a central study team by 30 days after the end of their respective data study period.

Any hospital worldwide that performs emergency trauma surgery will be eligible to participate, including both trauma centres and trauma units; a minimum of 1 case must be submitted by the centre during the 30 day study period to be eligible. Each centre's team will be comprised of a local study lead, with maximum 3 members of the local study team for each data collection period. Independent data validators will be also required for select centres.

We will include patients of all ages who present to hospital with a blunt or penetrating injury and undergo a trauma laparotomy within 5 days of presentation to the treating centre (day 0 being time of presentation). A patient will be included for final analysis if >70% of the data points required have been recorded.

Exclusion criteria are:

  • Patients undergoing a laparotomy ≥ 5 days (i.e. 120 hours) since presentation to the treating centre
  • Any relook laparotomy, including transfers from another centre for further and / or definitive surgery
  • Any laparoscopic (including laparoscopic converted to open), robotic, or image-guided procedures
  • Patients who have been recently discharged from any hospital (including for non-trauma related admissions) and have represented within 30 days of discharge

We aim to collect system, patient, process, and outcome data. A data set will be collected on all patients undergoing a trauma laparotomy within the inclusion period. The included data fields were based on work by similar studies and refined through iterative consultation with a global interdisciplinary consortium of clinicians involved in trauma care.

Data will be collected through access to patient records only at each centre, performed by members of the local study team. The patient will not be contacted directly in any capacity during their inpatient stay or after the study and no direct involvement in patient care will occur. Data will be collected directly onto a well-established secure web-based system, REDCap cloud (or recorded temporarily onto a hard copy Data Collection Form and uploaded to REDCap at a later date)

The data collected will include a pragmatic set of variables that allow the proposed research to be conducted, but minimise both risk of identification and exclude extraneous possibly sensitive medical information. Local requisite ethics and approvals will be applied for and be in place before any data collection occurs.

Being tested
Trauma Laparotomy
Medical subject headings
Abdominal Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Trauma LaparotomyProcedure or surgery

    Emergency abdominal surgery through midline incision to access abdominal and / or pelvic organs, to access identified injuries or exploratory diagnostic reasons

Study groups in NCT06180668
Study groupRoleWhat they receive
Trauma Laparotomy PatientsPatients of all ages who present to hospital with a blunt or penetrating injury and undergo a trauma laparotomy within 5 days of presentation to the treating centre
Receives: Procedure: Trauma Laparotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mortality

    All cause 30-day post-operative mortality rate

    Measured: 30 days post-operatively

Secondary outcomes (3)
  1. Length of Hospital Stay

    Time in hospital, from the operation until discharge

    Measured: 30 days post-operatively

  2. Morbidity Rates

    Any post-operative morbidity that occurred to the patient, as defined by the adapted Clavien-Dindo in trauma scale

    Measured: 30 days post-operatively

  3. Discharge Destination

    At time of discharge or stepdown from hospital, location the patient was discharged

    Measured: 30 days post-operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2023
  2. Study startApr 2024 (estimated)
  3. Primary completionDec 2024 (estimated)
  4. Study completionFeb 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
552 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06180668
Sponsor's protocol ID
GlobalTraumaLaprotomy
Acronym
GOAL-Trauma
Status last verified
Dec 2023
First submitted
12 Dec 2023
Last updated
22 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Aziz R, Bath MF, Abdelmohsen SM, Chukwu I, Saleh R, Caceres E, Nuno-Guzman CM, Amoako J, Nagraj S, Karusoke DK, Hobbs L, Smith BG, Kohler K, Hardcastle TC, Perkins ZB, Weiser TG, Lakhoo K, Bashford T; GOAL-Trauma Collaborative. Global variation in injury patterns, interventions, and post-operative outcomes for children and adolescents undergoing trauma laparotomy: an international cohort study. Lancet Child Adolesc Health. 2026 Jul;10(7):505-514. doi: 10.1016/S2352-4642(26)00069-6. Epub 2026 May 7.

    PubMed 42107384
  • Ng WH, Bath MF, Amoako J, Kohler K, Baderhabusha DU, Caceres E, Nuno-Guzman CM, Moonesinghe R, Hobbs L, Smith BG, Weiser TG, Hardcastle TC, Perkins ZB, Bashford T; GOAL-Trauma Collaborative. Use of pre-operative blood products in abdominal trauma: a planned secondary analysis of the GOAL-trauma study. EClinicalMedicine. 2026 Mar 4;93:103814. doi: 10.1016/j.eclinm.2026.103814. eCollection 2026 Mar.

    PubMed 41938841
  • Bath MF, Amoako J, Kohler K, Hashi AS, Zhang Z, Baderhabusha DU, Caceres E, Nuno-Guzman CM, Marsden M, Carenzo L, Khajanchi M, Saleh R, Edmiston T, Hammer C, Hobbs L, Smith BG, Hutchinson P, Weiser TG, Perkins ZB, Hardcastle TC, Bashford T; GOAL-Trauma Collaborative. Global variation in patient factors, interventions, and postoperative outcomes for those undergoing trauma laparotomy: an international, prospective, observational cohort study. Lancet Glob Health. 2025 Nov;13(11):e1837-e1848. doi: 10.1016/S2214-109X(25)00303-1. Epub 2025 Sep 16.

    PubMed 40972623

Questions about this trial

What is this clinical trial studying?

An observational study of Abdominal Trauma, run by University of Cambridge.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Michael F Bath, MBChB (+44 (0)1223748577, mb2583@cam.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mortality (time frame: 30 days post-operatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06180668, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in